이상반응 보고
| VAERS ID | 1669705 |
|---|---|
| 성별 | 여성 |
| 나이 | 29세 |
| 주 코드 | FR |
| 제약회사 | MODERNA |
| 로트 번호 | |
| 예방접종 횟수 | 1 |
| 접종일 | 2021-07-28 |
| 발병일 | 2021-07-28 |
| 상태 | 입원 회복 |
증상
- 임신 중 노출(Exposure during pregnancy)
- 심근염(Myocarditis)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
Myopericarditis; vaccine exposure during pregnancy; This case was received via Agency Regulatory Authority (Reference number: ES-AEMPS-980638) on 26-Aug-2021 and was forwarded to Moderna on 26-Aug-2021.
This regulatory authority prospective pregnancy case was reported by a physician and describes the occurrence of MYOCARDITIS (Myopericarditis) in a 29-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.
The occurrence of additional non-serious events is detailed below.
No Medical History information was reported.
On 28-Jul-2021, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .
5 milliliter.
The patient's last menstrual period was on 03-Dec-2020 and the estimated date of delivery was 09-Sep-2021.
On 28-Jul-2021, after starting mRNA-1273 (Spikevax), the patient experienced EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy).
On 30-Jul-2021, the patient experienced MYOCARDITIS (Myopericarditis) (seriousness criteria hospitalization and medically significant).
The patient received mRNA-1273 (Spikevax) beginning around the thirty-third week of the pregnancy.
On 05-Aug-2021, MYOCARDITIS (Myopericarditis) had resolved.
At the time of the report, EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) outcome was unknown.
mRNA-1273 (Spikevax) (Intramuscular) was withdrawn on 28-Jul-2021.
For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.
No concomitant medications were reported No treatment medications were reported.
This is a case of product exposure during pregnancy with associated AEs for this 29-year-old female.
Based on the current available information and temporal association between the use of the product and the start date of the event Myopericarditis, a causal relationship cannot be excluded.
; Sender's Comments: This is a case of product exposure during pregnancy with associated AEs for this 29-year-old female.
Based on the current available information and temporal association between the use of the product and the start date of the event Myopericarditis, a causal relationship cannot be excluded.